Wednesday, July 8, 2026

pharma · Postoperative Pain · Pain · PCRX

Pacira Ireland

Pacira Ireland is a pharma organization headquartered in Ranelagh, IE. It trades on NYSE under ticker PCRX. Primary therapeutic focus areas include Postoperative Pain, Pain, Postoperative Pain Management, Osteoarthritis,

Ranelagh, IE HQ
2007 Founded
7 Employees
Public company Type
PCRX · NYSE Ticker
Company details
Status
Public
HQ
Ranelagh, IE
Founded
2007
Employees
7
Programs
100
Drugs
32
Patents
57
Clinical program

Enekinragene Inzadenovec (PCRX-201)

Phase 2 · mab · Osteoarthritis (OA) of the Knee

Enekinragene Inzadenovec (PCRX-201) for Osteoarthritis (OA) of the Knee is a Phase 2 program (mab) at Pacira Ireland Limited with 1 ClinicalTrials.gov record(s).

Internal code 201-C-201

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pacira Ireland Limited
Phase
Phase 2
Modality
mab
Indication
Osteoarthritis (OA) of the Knee
Status
active
Trials
1

Clinical trials